Sinico Renato Alberto, Di Toma Lucafrancesco, Maggiore Umberto, Tosoni Cinzia, Bottero Paolo, Sabadini Ettore, Giammarresi Gaia, Tumiati Bruno, Gregorini Gina, Pesci Alberto, Monti Stefano, Balestrieri Genesio, Garini Giovanni, Vecchio Filomena, Buzio Carlo
Dipartimento Area Medica, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milan, Italy.
Am J Kidney Dis. 2006 May;47(5):770-9. doi: 10.1053/j.ajkd.2006.01.026.
Churg-Strauss syndrome (CSS) is a rare disorder characterized by asthma, eosinophilia, and systemic vasculitis. Renal involvement is not regarded as a prominent feature, and its prevalence and severity vary widely in published reports that usually refer to small series of selected patients.
We examined the prevalence, clinicopathologic features, and prognosis of renal disease in 116 patients with CSS.
There were 48 men and 68 women with a mean age of 51.9 years (range, 18 to 86 years). Signs of renal abnormalities were present in 31 patients (26.7%). Rapidly progressive renal insufficiency was documented in 16 patients (13.8%); urinary abnormalities, 14 patients (12.1%); and chronic renal impairment, 1 patient. There were 3 additional cases of obstructive uropathy. Sixteen patients underwent renal biopsy, which showed necrotizing crescentic glomerulonephritis in 11 patients. Other diagnoses were eosinophilic interstitial nephritis, mesangial glomerulonephritis, and focal sclerosis. Antineutrophil cytoplasmic antibody (ANCA) was positive in 21 of 28 patients (75.0%) with nephropathy versus 19 of 74 patients without (25.7%; P < 0.001). In particular, all patients with necrotizing crescentic glomerulonephritis were ANCA positive. After a median follow-up of 4.5 years, 10 patients died (5 patients with nephropathy) and 7 patients developed mild chronic renal insufficiency. Five-year mortality rates were 11.7% (95% confidence interval, 3.9 to 33.3) in patients with nephropathy and 2.7% (95% confidence interval, 0.7 to 10.7) in those without (P = 0.10).
Renal abnormalities are present in about one quarter of patients with CSS. The prevailing picture is ANCA-associated necrotizing crescentic glomerulonephritis; however, other forms of nephropathy also may occur. Outcome and long-term follow-up usually are good.
变应性肉芽肿性血管炎(CSS)是一种罕见疾病,其特征为哮喘、嗜酸性粒细胞增多和系统性血管炎。肾脏受累并不被视为突出特征,在已发表的报告中其患病率和严重程度差异很大,这些报告通常涉及一小部分选定患者。
我们研究了116例CSS患者的肾脏疾病患病率、临床病理特征和预后。
有48例男性和68例女性,平均年龄51.9岁(范围18至86岁)。31例患者(26.7%)存在肾脏异常体征。16例患者(13.8%)记录有快速进展性肾功能不全;14例患者(12.1%)有尿液异常;1例患者有慢性肾功能损害。另有3例梗阻性尿路病病例。16例患者接受了肾活检,其中11例显示为坏死性新月体性肾小球肾炎。其他诊断包括嗜酸性粒细胞性间质性肾炎、系膜增生性肾小球肾炎和局灶性节段性肾小球硬化。肾病患者中28例有21例(75.0%)抗中性粒细胞胞浆抗体(ANCA)阳性,而无肾病的74例患者中有19例(25.7%)阳性(P<0.001)。特别是,所有坏死性新月体性肾小球肾炎患者ANCA均为阳性。中位随访4.5年后,10例患者死亡(5例肾病患者),7例患者出现轻度慢性肾功能不全。肾病患者的5年死亡率为11.7%(95%置信区间,3.9至33.3),无肾病患者为2.7%(95%置信区间,0.7至10.7)(P = 0.10)。
约四分之一的CSS患者存在肾脏异常。主要表现为ANCA相关性坏死性新月体性肾小球肾炎;然而,也可能出现其他形式的肾病。通常预后及长期随访情况良好。